Rajesh Peter, Hammad Bajwa, Sony Anthony. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Benzhydryl CompoundsBlood Pressure/drug effectsCardiovascular Diseases/drug therapyCardiovascular Diseases/metabolismClinical Trials as TopicDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/metabolismDiabetes Mellitus, Type 2/pathologyGlucagon-Like Peptide 1/analogs & derivativesGlucosides/pharmacologyHumansHyperlipidemias/drug therapyHyperlipidemias/metabolismHypoglycemic Agents/pharmacologyRisk FactorsSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsTreatment Outcome
Substances： See more » Benzhydryl CompoundsGlucosidesHypoglycemic AgentsSLC5A2 protein, humanSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsdapagliflozinGlucagon-Like Peptide 1
Year: 2013 PMID： 23481234 DOI： 10.1097/MOL.0b013e32835ec5f5
Source DB: PubMed Journal: Curr Opin Lipidol ISSN： 0957-9672 Impact factor: 4.776